London based asset management house, Morley Fund Management, has hired two analysts for its biotechnology and healthcare research team.
Both analysts, Richard Purkiss - who will be based in London - and Henry Astarjian - who will be based in Boston - will report to Donald Tosh, head of corporate research.
Purkiss will focus on the pan-European biotechnology and healthcare sectors while Astarjian, joining from Boston based fund manager Gannett, Welsh & Kotler, will be responsible for covering biotechnology and pharmaceutical industries.
By Resham Bhojwani
Professional Pensions is looking to update its list of pensions master trusts in the UK ahead of authorisation. Can you help?
RPMI Railpen is in the next step in the journey towards achieving cost disclosure. Victoria Bell tells Stephanie Baxter about taking part in the Cost Transparency Initiative's pilot phase
Interserve's numerous defined benefit (DB) schemes have retained a sponsor link after the company entered into administration and was sold.
Chris Hannon has been named chairman of the Railways Pensions Trustee Company after a unanimous vote of approval from its board last week.